USE OF BRAIN NATRIURETIC PEPTIDES (BNP), PHOSPHORYLATED URODILATINE, PHOSPHORYLATED CDD/ANP AND COMBINATIONS THEREOF

摘要

Use of a pharmaceutic composition containing brain natriuretic peptide (BNP), phosphorylated urodilatin (P-Uro), phosphorylated ANP (P-CDD/ANP) or combinations thereof as well as optionally pharmaceutically usual diluents, vehicles, fillers or auxiliary agents, for the treatment of pulmonary and bronchial diseases.